This study evaluates the superiority of daily self-pH monitorization of Lit-control®pH meter compared to the monitorization of reactive strips (standard of care).
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percentage of days with pH levels within range 7 and 8, during 6 months of home self-monitoring.
Timeframe: 183 measurements (morning) in 6 months.
Percentage of days with pH levels within range 7 and 8, during 6 months of home self-monitoring.
Timeframe: 183 measurements (afternoon) in 6 months.
Measurement of the volume of crystalluria.
Timeframe: 1 measurement at the moment of enrollment
Measurement of the volume of crystalluria.
Timeframe: 1 measurement at 6 months
Blood: DNA extraction.
Timeframe: 1 measurement at the moment of enrollment
Sediment analysis for the determination of urinary infection.
Timeframe: 1 measurement at the moment of enrollment
Sediment analysis for the determination of urinary infection.
Timeframe: 1 measurement at 6 months
Total time within the margins established as safe in the pH control (months).
Timeframe: 1 measurement through study completion [up to 6 months]
Adherence level in pH measurements
Timeframe: Through study completion, fraction of pH measurements on the total possible. [up to 6 months]
Adherence level to treatment
Timeframe: Through study completion, fraction of intakes on the total possible. [up to 6 months]
Total number of adverse events reported.
Timeframe: Through study completion, number of events. [up to 6 months]
Blood Analysis. Glucose
Timeframe: Change from Baseline measurement at 6 months
Blood Analysis. Calcium phosphate
Timeframe: Change from Baseline measurement at 6 months
Blood Analysis. Estimated Glomolecular Filtration Chronic Kidney Disease Epidemiology Collaboration (FG CKD-EPI)
Timeframe: Change from Baseline measurement at 6 months
Blood Analysis. Cystatin
Timeframe: Change from Baseline measurement at 6 months
Blood Analysis. Creatinine
Timeframe: Change from Baseline measurement at 6 months
Blood Analysis. Urate
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Weight
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Size
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Urinary volume
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Calcium phosphate
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Citrate
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Urate
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Magnesium
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Sodium
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. BMI
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Potassium
Timeframe: Change from Baseline measurement at 6 months
24h Urine Analysis. Urea
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Schedule
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Crystalline volume
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Crystals
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Urine volume
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. pH
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Size
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Density
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Aggregation
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Twinning
Timeframe: Change from Baseline measurement at 6 months
Urine for the study of crystalluria. Quotient
Timeframe: Change from Baseline measurement at 6 months